Ars Pharmaceuticals, Inc. · NASDAQ:SPRY
Ars Pharmaceuticals, Inc. shareholders
As of Jun 30, 2026, 200 institutions reported holding Ars Pharmaceuticals, Inc., 91.2% of its shares. Largest: Ra Capital Management, L.P., Rubric Capital Management LP and Orbimed Advisors LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Ars Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| Ra Capital Management, L.P. | 10.9M | 10.9% | no change | Aug 14, 2026 |
| Rubric Capital Management LP | 8.54M | 8.6% | +541K | Aug 14, 2026 |
| Orbimed Advisors LLC | 8.29M | 8.3% | no change | Aug 14, 2026 |
| Deerfield Management Company, L.P. | 7.5M | 7.5% | no change | Aug 14, 2026 |
| BlackRock | 5.31M | 5.3% | +299K | Aug 7, 2026 |
| Tyro Capital Management LLC | 4.46M | 4.5% | held for review | Aug 13, 2026 |
| abrdn | 4.17M | 4.2% | +57,012 | Jul 31, 2026 |
| SR One Capital Management, LP | 4.01M | 4.0% | no change | Aug 12, 2026 |
| State Street | 3.73M | 3.8% | +85,657 | Aug 7, 2026 |
| Vanguard | 3.66M | 3.7% | +81,996 | Aug 13, 2026 |